These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 11806809)
1. Debate: PCI or CABG for multivessel disease? Viewpoint: No clear winner in an unfair fight. Bhatt DL; Topol EJ Curr Control Trials Cardiovasc Med; 2001; 2(6):260-262. PubMed ID: 11806809 [TBL] [Abstract][Full Text] [Related]
2. Stroke Rates Following Surgical Versus Percutaneous Coronary Revascularization. Head SJ; Milojevic M; Daemen J; Ahn JM; Boersma E; Christiansen EH; Domanski MJ; Farkouh ME; Flather M; Fuster V; Hlatky MA; Holm NR; Hueb WA; Kamalesh M; Kim YH; Mäkikallio T; Mohr FW; Papageorgiou G; Park SJ; Rodriguez AE; Sabik JF; Stables RH; Stone GW; Serruys PW; Kappetein AP J Am Coll Cardiol; 2018 Jul; 72(4):386-398. PubMed ID: 30025574 [TBL] [Abstract][Full Text] [Related]
3. Comparison of bypass surgery and stenting for the treatment of multivessel disease: results from the ARTS trial in Israel. Gruberg L; Milo S; Ben Tzvi M; Lotan C; Merin G; Braun S; Mohr R; Tzivoni D; Bitran D; Beyar R; Isr Med Assoc J; 2003 Aug; 5(8):539-42. PubMed ID: 12929288 [TBL] [Abstract][Full Text] [Related]
4. Multivessel coronary revascularization in patients with and without diabetes mellitus: 3-year follow-up of the ARTS-II (Arterial Revascularization Therapies Study-Part II) trial. Daemen J; Kuck KH; Macaya C; LeGrand V; Vrolix M; Carrie D; Sheiban I; Suttorp MJ; Vranckx P; Rademaker T; Goedhart D; Schuijer M; Wittebols K; Macours N; Stoll HP; Serruys PW; J Am Coll Cardiol; 2008 Dec; 52(24):1957-67. PubMed ID: 19055986 [TBL] [Abstract][Full Text] [Related]
5. The Bypass Angioplasty Revascularization in Type 1 and Type 2 Diabetes Study: 5-year follow-up of revascularization with percutaneous coronary intervention versus coronary artery bypass grafting in diabetic patients with multivessel disease. Kapur A; Bartolini D; Finlay MC; Qureshi AC; Flather M; Strange JW; Hall RJ J Cardiovasc Med (Hagerstown); 2010 Jan; 11(1):26-33. PubMed ID: 19797974 [TBL] [Abstract][Full Text] [Related]
6. Long-term safety and efficacy of percutaneous coronary intervention with stenting and coronary artery bypass surgery for multivessel coronary artery disease: a meta-analysis with 5-year patient-level data from the ARTS, ERACI-II, MASS-II, and SoS trials. Daemen J; Boersma E; Flather M; Booth J; Stables R; Rodriguez A; Rodriguez-Granillo G; Hueb WA; Lemos PA; Serruys PW Circulation; 2008 Sep; 118(11):1146-54. PubMed ID: 18725490 [TBL] [Abstract][Full Text] [Related]
7. Association of chronic kidney disease with clinical outcomes after coronary revascularization: the Arterial Revascularization Therapies Study (ARTS). Ix JH; Mercado N; Shlipak MG; Lemos PA; Boersma E; Lindeboom W; O'Neill WW; Wijns W; Serruys PW Am Heart J; 2005 Mar; 149(3):512-9. PubMed ID: 15864241 [TBL] [Abstract][Full Text] [Related]
8. Diabetes and coronary revascularization. Flaherty JD; Davidson CJ JAMA; 2005 Mar; 293(12):1501-8. PubMed ID: 15784875 [TBL] [Abstract][Full Text] [Related]
9. Randomized comparison of percutaneous coronary intervention with coronary artery bypass grafting in diabetic patients. 1-year results of the CARDia (Coronary Artery Revascularization in Diabetes) trial. Kapur A; Hall RJ; Malik IS; Qureshi AC; Butts J; de Belder M; Baumbach A; Angelini G; de Belder A; Oldroyd KG; Flather M; Roughton M; Nihoyannopoulos P; Bagger JP; Morgan K; Beatt KJ J Am Coll Cardiol; 2010 Feb; 55(5):432-40. PubMed ID: 20117456 [TBL] [Abstract][Full Text] [Related]
10. Comparison of coronary artery bypass surgery and percutaneous coronary intervention in patients with diabetes: a meta-analysis of randomised controlled trials. Verma S; Farkouh ME; Yanagawa B; Fitchett DH; Ahsan MR; Ruel M; Sud S; Gupta M; Singh S; Gupta N; Cheema AN; Leiter LA; Fedak PW; Teoh H; Latter DA; Fuster V; Friedrich JO Lancet Diabetes Endocrinol; 2013 Dec; 1(4):317-28. PubMed ID: 24622417 [TBL] [Abstract][Full Text] [Related]
11. Coronary Artery Bypass Surgery Versus Drug-Eluting Stent Implantation for Left Main or Multivessel Coronary Artery Disease: A Meta-Analysis of Individual Patient Data. Lee CW; Ahn JM; Cavalcante R; Sotomi Y; Onuma Y; Suwannasom P; Tenekecioglu E; Yun SC; Park DW; Kang SJ; Lee SW; Kim YH; Park SW; Serruys PW; Park SJ JACC Cardiovasc Interv; 2016 Dec; 9(24):2481-2489. PubMed ID: 28007199 [TBL] [Abstract][Full Text] [Related]
12. Coronary artery bypass grafting vs percutaneous coronary intervention and long-term mortality and morbidity in multivessel disease: meta-analysis of randomized clinical trials of the arterial grafting and stenting era. Sipahi I; Akay MH; Dagdelen S; Blitz A; Alhan C JAMA Intern Med; 2014 Feb; 174(2):223-30. PubMed ID: 24296767 [TBL] [Abstract][Full Text] [Related]
13. Impact of restenosis and disease progression on clinical outcome after multivessel stenting in diabetic patients. Loutfi M; Mulvihill NT; Boccalatte M; Farah B; Fajadet J; Marco J Catheter Cardiovasc Interv; 2003 Apr; 58(4):451-4. PubMed ID: 12652493 [TBL] [Abstract][Full Text] [Related]
14. Clinical and economic outcomes of multivessel coronary stenting compared with bypass surgery: a single-center US experience. Reynolds MR; Neil N; Ho KK; Berezin R; Cosgrove RS; Lager RA; Sirois C; Johnson RG; Cohen DJ Am Heart J; 2003 Feb; 145(2):334-42. PubMed ID: 12595853 [TBL] [Abstract][Full Text] [Related]
15. Clinical and economic impact of diabetes mellitus on percutaneous and surgical treatment of multivessel coronary disease patients: insights from the Arterial Revascularization Therapy Study (ARTS) trial. Abizaid A; Costa MA; Centemero M; Abizaid AS; Legrand VM; Limet RV; Schuler G; Mohr FW; Lindeboom W; Sousa AG; Sousa JE; van Hout B; Hugenholtz PG; Unger F; Serruys PW; Circulation; 2001 Jul; 104(5):533-8. PubMed ID: 11479249 [TBL] [Abstract][Full Text] [Related]
16. Individual Long-Term Mortality Prediction Following Either Coronary Stenting or Bypass Surgery in Patients With Multivessel and/or Unprotected Left Main Disease: An External Validation of the SYNTAX Score II Model in the 1,480 Patients of the BEST and PRECOMBAT Randomized Controlled Trials. Sotomi Y; Cavalcante R; van Klaveren D; Ahn JM; Lee CW; de Winter RJ; Wykrzykowska JJ; Onuma Y; Steyerberg EW; Park SJ; Serruys PW JACC Cardiovasc Interv; 2016 Aug; 9(15):1564-72. PubMed ID: 27491605 [TBL] [Abstract][Full Text] [Related]
17. One-year results of coronary revascularization in diabetic patients with multivessel coronary artery disease.Sirolimus stent vs. coronary artery bypass surgery and bare metal stent: insights from ARTS-II and ARTS-I. Macaya C; García-García HM; Colombo A; Morice MC; Legrand V; Kuck KH; Sheiban I; Suttorp MJ; Carrie D; Vrolix M; Wittebols K; Stoll HP; Donohoe D; Bressers M; Serruys PW EuroIntervention; 2006 May; 2(1):69-76. PubMed ID: 19755239 [TBL] [Abstract][Full Text] [Related]
18. Coronary artery bypass graft surgery vs percutaneous interventions in coronary revascularization: a systematic review. Deb S; Wijeysundera HC; Ko DT; Tsubota H; Hill S; Fremes SE JAMA; 2013 Nov; 310(19):2086-95. PubMed ID: 24240936 [TBL] [Abstract][Full Text] [Related]
19. Design of the Future REvascularization Evaluation in patients with Diabetes mellitus: Optimal management of Multivessel disease (FREEDOM) Trial. Farkouh ME; Dangas G; Leon MB; Smith C; Nesto R; Buse JB; Cohen DJ; Mahoney E; Sleeper L; King S; Domanski M; McKinlay S; Fuster V Am Heart J; 2008 Feb; 155(2):215-23. PubMed ID: 18215589 [TBL] [Abstract][Full Text] [Related]
20. Long-Term Mortality After Coronary Revascularization in Nondiabetic Patients With Multivessel Disease. Chang M; Ahn JM; Lee CW; Cavalcante R; Sotomi Y; Onuma Y; Tenekecioglu E; Han M; Park DW; Kang SJ; Lee SW; Kim YH; Park SW; Serruys PW; Park SJ J Am Coll Cardiol; 2016 Jul; 68(1):29-36. PubMed ID: 27364047 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]